跳至主要内容
临床试验/ISRCTN88894088
ISRCTN88894088已完成未知

Open-label, randomised multicentre study of CAMPATH-1H versus basiliximab induction treatment and sirolimus versus tacrolimus maintenance treatment for the preservation of renal function in patients receiving kidney transplants

niversity of Oxford (UK)0 个研究点目标入组 394 人开始时间: 2010年6月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
394

研究概览

简要总结

  1. 2014 results in: http://www.ncbi.nlm.nih.gov/pubmed/25078310 2. 2019 results in: https://www.ncbi.nlm.nih.gov/pubmed/29226570 (added 18/12/2019)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Men or women aged over 18 years
  • 2. Recipient of kidney transplant from live or deceased donor

排除标准

  • 1. Recipients of multi-organ transplants
  • 2. Previous treatment with Campath-1H
  • 3. Active infection
  • 4. Past history of anaphylaxis to humanized monoclonal antibodies
  • 5. History of malignancy (except for adequately treated non-melanoma skin cancer)
  • 6. Loss of previous transplant within 6 months not due to technical reasons
  • 7. Medical history that might limit the participant's ability to take trial treatments for the duration of the study

研究者

发起方
niversity of Oxford (UK)

相似试验